Allahabad HC Puts On Hold UP’s Order To Suspend Sanjay Gandhi Hospital’s Licence

Lucknow/Amethi: The Lucknow bench of Allahabad High Court on Wednesday stayed the Uttar Pradesh government’s order suspending the licence of Sanjay Gandhi Hospital in Amethi.

A division bench of Justices Vivek Chaudhary and Manish Kumar said that inquiry against the hospital would go on. The bench also asked the state government to file its counter affidavit.

The bench was hearing a petition filed by the Sanjay Gandhi Hospital administration against the government’s order.

On September 18, the health department suspended the licence of Sanjay Gandhi Hospital in Munshiganj area of Amethi and halted OPD and emergency services, days after the death of a woman patient following an operation.

The hospital is run by Sanjay Gandhi Memorial Trust (SGMT) headed by Congress leader Sonia Gandhi.

Manoj Muttu, administrator of the trust, told PTI that a copy of the court’s order will be submitted to the chief medical officer of Amethi and as per the CMO’s directions functioning of the hospital will resume.

However, Muttu said he would like the hospital to resume functioning from Thursday.

On September 27, over 400 employees of the hospital sat on a dharna against the suspension of its licence. Local Congress leaders also staged a protest outside the CMO’s office.

The woman patient, Divya (22) who was admitted to the Sanjay Gandhi Hospital on September 14, went into a coma during a surgery. Her family members alleged that she was kept at the hospital for more than 30 hours before being referred to Lucknow where she died on September 16.

The next day, an FIR of causing death by negligence was registered against four employees of the hospital, including its chief executive officer.

Related Posts

  • Pharma
  • July 26, 2024
  • 123 views
US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

  • Pharma
  • July 26, 2024
  • 117 views
Indian National Charged With Selling Counterfeit Cancer Drugs

HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD